NOVEL CRYSTALLINE POLYMORPHIC FORMS OF LERCANIDIPINE HYDROCHLORIDE AND PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE CRYSTALLINE FORMS
The invention describes novel lercanidipine hydrochloride crystalline Form (I) pharmaceutical, antihypertensive compositions containing as active agent a mixture of the lercanidipine hydrochloride crystalline form (I) with the amorphous form and optionally lercanidipine hydrochloride crystalline form (II). <;CHEM>;